CUSIP: 88907J107
Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,709,561
-
Share change
-
+540,289
-
Total reported value
-
$69,442,087
-
Price per share
-
$10.35
-
Number of holders
-
48
-
Value change
-
+$3,874,483
-
Number of buys
-
28
-
Number of sells
-
15
Quarterly Holders Quick Answers
What is CUSIP 88907J107?
CUSIP 88907J107 identifies TKAI - TOKAI PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2015
-
Previous quarter:
Q2 2015
Recent filing periods for CUSIP 88907J107:
Institutional Holders of TOKAI PHARMACEUTICALS INC - COM (TKAI) as of Q3 2015
As of 30 Sep 2015,
TOKAI PHARMACEUTICALS INC - COM (TKAI) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,709,561 shares.
The largest 10 holders included
Novo A/S, KINGDON CAPITAL MANAGEMENT, L.L.C., SABBY MANAGEMENT, LLC, Bank of New York Mellon Corp, FMR LLC, PERCEPTIVE ADVISORS LLC, FRANKLIN RESOURCES INC, Alyeska Investment Group, L.P., BlackRock Fund Advisors, and VANGUARD GROUP INC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.